Symbols / IRTC Stock $109.17 -4.15% iRhythm Holdings, Inc.

Healthcare • Medical Devices • United States • NMS
IRTC (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Devices
CEO Mr. Quentin S. Blackford
Exch · Country NMS · United States
Market Cap 3.59B
Enterprise Value 3.77B
Income -27.78M
Sales 787.85M
FCF (ttm) 57.02M
Book/sh 4.91
Cash/sh 16.73
Employees 2,400
Insider 10d —
IPO Oct 20, 2016
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 103.84
PEG —
P/S 4.55
P/B 22.25
P/C —
EV/EBITDA -337.42
EV/Sales 4.78
Quick Ratio 4.79
Current Ratio 5.17
Debt/Eq 452.39
LT Debt/Eq —
EPS (ttm) -0.85
EPS next Y 1.05
EPS Growth —
Revenue Growth 25.70%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-07-30
Earnings (prior) 2026-04-30
ROA -1.15%
ROE -22.42%
ROIC —
Gross Margin 71.00%
Oper. Margin -5.95%
Profit Margin -3.53%
Shs Outstand 32.86M
Shs Float 30.81M
Insider Own 1.14%
Instit Own 110.98%
Short Float 9.53%
Short Ratio 6.03
Short Interest 3.10M
52W High 212.00
vs 52W High -48.50%
52W Low 108.81
vs 52W Low 0.33%
Beta 1.33
Impl. Vol. 0.39%
Rel Volume 0.79
Avg Volume 533.94K
Volume 421.22K
Target (mean) $178.93
Tgt Median $177.50
Tgt Low $147.00
Tgt High $255.00
# Analysts 14
Recom Strong_buy
Prev Close $113.90
Price $109.17
Change -4.15%
About

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$178.93
Mean price target
2. Current target
$109.17
Latest analyst target
3. DCF / Fair value
$31.23
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$109.17
Low
$147.00
High
$255.00
Mean
$178.93

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-06-01 main Canaccord Genuity Buy → Buy $152
2026-05-18 main B of A Securities Buy → Buy $180
2026-05-04 main Citigroup Buy → Buy $157
2026-05-01 main Canaccord Genuity Buy → Buy $180
2026-05-01 main JP Morgan Overweight → Overweight $175
2026-05-01 main Wells Fargo Overweight → Overweight $180
2026-05-01 main Evercore ISI Group Outperform → Outperform $160
2026-05-01 main Needham Buy → Buy $255
2026-04-15 main Truist Securities Buy → Buy $170
2026-04-09 main Goldman Sachs Neutral → Neutral $147
2026-04-06 main Evercore ISI Group Outperform → Outperform $170
2026-03-11 main Citigroup Buy → Buy $214
2026-02-23 reit Truist Securities Buy → Buy $200
2026-02-20 main Canaccord Genuity Buy → Buy $198
2026-02-20 main JP Morgan Overweight → Overweight $215
2026-02-20 main Wells Fargo Overweight → Overweight $200
2026-02-20 main Baird Outperform → Outperform $200
2026-01-13 main Wells Fargo Overweight → Overweight $225
2026-01-12 reit Needham Buy → Buy $244
2026-01-05 up Evercore ISI Group In-Line → Outperform $210
News
RSS: Latest IRTC news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-27 BAIREY MERZ CATHLEEN NOEL Director — 1,573 $0.00 $0
2026-05-27 BODAKEN BRUCE G Director — 1,573 $0.00 $0
2026-05-27 LING KAREN Director — 1,573 $0.00 $0
2026-05-27 YOOR BRIAN B. Director — 1,573 $0.00 $0
2026-05-11 TALWALKAR ABHIJIT Y Director — 5,312 $10.71 $56,892
2026-05-11 TALWALKAR ABHIJIT Y Director — 5,312 $116.05 $626,430
2026-05-11 TALWALKAR ABHIJIT Y Director — 5,312 $116.84 $620,654
2026-05-04 LAWRENCE BRIAN LEE Chief Technology Officer — 1,014 $120.80 $122,491
2026-03-16 SMITH MERVIN Officer — 2,585 $114.30 $295,466
2026-03-02 WILSON DANIEL G Chief Financial Officer — 3,395 $128.44 $436,076
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
747.14
+26.24%
591.84
+20.13%
492.68
+19.90%
410.92
Operating Revenue
747.14
+26.24%
591.84
+20.13%
492.68
+19.90%
410.92
Cost Of Revenue
219.89
+19.30%
184.31
+14.57%
160.88
+24.43%
129.29
Reconciled Cost Of Revenue
219.89
+19.30%
184.31
+14.57%
160.88
+24.43%
129.29
Gross Profit
527.25
+29.38%
407.53
+22.82%
331.81
+17.82%
281.63
Operating Expense
580.20
+11.07%
522.39
+17.16%
445.89
+20.90%
368.81
Research And Development
87.65
-15.59%
103.83
+72.35%
60.24
+29.25%
46.61
Selling General And Administration
492.55
+17.68%
418.56
+8.54%
385.64
+19.69%
322.20
Total Expenses
800.09
+13.21%
706.70
+16.47%
606.76
+21.82%
498.10
Operating Income
-52.95
+53.90%
-114.86
-0.68%
-114.08
-30.87%
-87.18
Total Operating Income As Reported
-57.41
+50.30%
-115.50
+7.71%
-125.16
-10.00%
-113.78
EBITDA
-3.96
+94.65%
-74.13
+23.47%
-96.86
-5.13%
-92.14
Normalized EBITDA
0.49
+100.75%
-65.90
+23.18%
-85.78
-30.91%
-65.53
Reconciled Depreciation
26.48
+2.72%
25.78
+16.41%
22.14
+12.93%
19.61
EBIT
-30.44
+69.53%
-99.90
+16.05%
-119.01
-6.49%
-111.75
Total Unusual Items
-4.46
+45.83%
-8.23
+25.71%
-11.08
+58.37%
-26.61
Total Unusual Items Excluding Goodwill
-4.46
+45.83%
-8.23
+25.71%
-11.08
+58.37%
-26.61
Special Income Charges
-4.46
+45.83%
-8.23
+25.71%
-11.08
+58.37%
-26.61
Other Special Charges
3.04
-59.99%
7.59
—
—
Impairment Of Capital Assets
4.46
+595.48%
0.64
-94.21%
11.08
-52.18%
23.16
Restructuring And Mergern Acquisition
—
0.00
0.00
-100.00%
3.44
Write Off
—
0.64
0.00
0.00
Net Income
-44.55
+60.67%
-113.29
+8.20%
-123.41
-6.24%
-116.16
Pretax Income
-43.60
+61.32%
-112.72
+8.10%
-122.66
-5.84%
-115.89
Net Non Operating Interest Income Expense
8.37
-8.23%
9.12
+237.29%
2.70
+251.17%
-1.79
Interest Expense Non Operating
13.15
+2.60%
12.82
+251.26%
3.65
-11.79%
4.14
Net Interest Income
8.37
-8.23%
9.12
+237.29%
2.70
+251.17%
-1.79
Interest Expense
13.15
+2.60%
12.82
+251.26%
3.65
-11.79%
4.14
Interest Income Non Operating
21.52
-1.90%
21.94
+245.32%
6.35
+170.34%
2.35
Interest Income
21.52
-1.90%
21.94
+245.32%
6.35
+170.34%
2.35
Other Income Expense
0.98
+114.10%
-6.98
+38.13%
-11.28
+58.12%
-26.92
Other Non Operating Income Expenses
5.44
+334.32%
1.25
+732.83%
-0.20
+36.94%
-0.31
Tax Provision
0.95
+68.67%
0.56
-24.67%
0.75
+178.81%
0.27
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-0.94
+45.83%
-1.73
+25.71%
-2.33
+58.37%
-5.59
Net Income Including Noncontrolling Interests
-44.55
+60.67%
-113.29
+8.20%
-123.41
-6.24%
-116.16
Net Income From Continuing Operation Net Minority Interest
-44.55
+60.67%
-113.29
+8.20%
-123.41
-6.24%
-116.16
Net Income From Continuing And Discontinued Operation
-44.55
+60.67%
-113.29
+8.20%
-123.41
-6.24%
-116.16
Net Income Continuous Operations
-44.55
+60.67%
-113.29
+8.20%
-123.41
-6.24%
-116.16
Normalized Income
-41.03
+61.58%
-106.79
+6.86%
-114.65
-20.52%
-95.13
Net Income Common Stockholders
-44.55
+60.67%
-113.29
+8.20%
-123.41
-6.24%
-116.16
Diluted EPS
-1.39
+61.71%
-3.63
+10.15%
-4.04
-4.12%
-3.88
Basic EPS
-1.39
+61.71%
-3.63
+10.15%
-4.04
-4.12%
-3.88
Basic Average Shares
32.00
+2.59%
31.20
+2.19%
30.53
+2.05%
29.92
Diluted Average Shares
32.00
+2.59%
31.20
+2.19%
30.53
+2.05%
29.92
Diluted NI Availto Com Stockholders
-44.55
+60.67%
-113.29
+8.20%
-123.41
-6.24%
-116.16
Line Item Trend 2025-12-31 2024-12-31
Total Assets
1,020.04
+9.51%
931.45
Current Assets
702.76
+8.82%
645.82
Cash Cash Equivalents And Short Term Investments
583.76
+9.00%
535.55
Cash And Cash Equivalents
236.01
-43.75%
419.60
Other Short Term Investments
347.75
+199.90%
115.96
Receivables
75.71
-5.30%
79.94
Accounts Receivable
75.71
-5.30%
79.94
Gross Accounts Receivable
90.34
-6.08%
96.19
Allowance For Doubtful Accounts Receivable
-14.63
+9.93%
-16.25
Inventory
21.63
+54.10%
14.04
Raw Materials
10.64
+81.56%
5.86
Finished Goods
10.99
+34.41%
8.18
Prepaid Assets
—
—
Other Current Assets
21.66
+33.01%
16.29
Total Non Current Assets
317.28
+11.08%
285.63
Net PPE
193.43
+12.03%
172.66
Gross PPE
284.62
+16.71%
243.88
Accumulated Depreciation
-91.19
-28.04%
-71.22
Properties
0.00
0.00
Machinery Furniture Equipment
100.17
+13.75%
88.07
Construction In Progress
96.02
+34.41%
71.44
Other Properties
59.45
+3.84%
57.25
Leases
28.98
+6.84%
27.12
Goodwill And Other Intangible Assets
0.86
+0.00%
0.86
Goodwill
0.86
+0.00%
0.86
Investments And Advances
69.91
+12.94%
61.90
Other Non Current Assets
53.08
+5.71%
50.21
Total Liabilities Net Minority Interest
867.30
+3.18%
840.54
Current Liabilities
151.89
+36.94%
110.92
Payables And Accrued Expenses
130.34
+42.39%
91.54
Payables
5.62
-57.59%
13.24
Accounts Payable
2.26
-68.76%
7.22
Other Payable
1.54
-23.32%
2.01
Current Accrued Expenses
124.73
+59.30%
78.30
Pensionand Other Post Retirement Benefit Plans Current
0.66
+13.16%
0.58
Total Tax Payable
1.82
-54.67%
4.01
Current Debt And Capital Lease Obligation
16.69
+5.16%
15.87
Current Debt
—
—
Other Current Borrowings
—
—
Current Capital Lease Obligation
16.69
+5.16%
15.87
Current Deferred Liabilities
4.20
+43.28%
2.93
Current Deferred Revenue
4.20
+43.28%
2.93
Total Non Current Liabilities Net Minority Interest
715.41
-1.95%
729.62
Long Term Debt And Capital Lease Obligation
714.50
-0.91%
721.04
Long Term Debt
649.50
+0.47%
646.44
Long Term Capital Lease Obligation
64.99
-12.88%
74.60
Other Non Current Liabilities
0.91
-89.42%
8.58
Stockholders Equity
152.75
+68.02%
90.91
Common Stock Equity
152.75
+68.02%
90.91
Capital Stock
0.03
+3.23%
0.03
Common Stock
0.03
+3.23%
0.03
Preferred Stock
0.00
0.00
Share Issued
32.53
+2.86%
31.62
Ordinary Shares Number
32.30
+2.88%
31.39
Treasury Shares Number
0.23
+0.00%
0.23
Additional Paid In Capital
980.76
+12.14%
874.61
Retained Earnings
-803.45
-5.87%
-758.89
Gains Losses Not Affecting Retained Earnings
0.40
+144.24%
0.17
Treasury Stock
25.00
+0.00%
25.00
Other Equity Adjustments
0.40
+144.24%
0.17
Total Equity Gross Minority Interest
152.75
+68.02%
90.91
Total Capitalization
802.25
+8.80%
737.35
Working Capital
550.88
+2.99%
534.90
Invested Capital
802.25
+8.80%
737.35
Total Debt
731.18
-0.78%
736.91
Net Debt
413.49
+82.28%
226.85
Capital Lease Obligations
81.68
-9.71%
90.47
Net Tangible Assets
151.88
+68.67%
90.05
Tangible Book Value
151.88
+68.67%
90.05
Interest Payable
—
—
Investmentin Financial Assets
69.91
+12.94%
61.90
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
80.86
+2285.34%
3.39
+106.77%
-50.10
-117.72%
-23.01
Cash Flow From Continuing Operating Activities
80.86
+2285.34%
3.39
+106.77%
-50.10
-117.72%
-23.01
Net Income From Continuing Operations
-44.55
+60.67%
-113.29
+8.20%
-123.41
-6.24%
-116.16
Depreciation Amortization Depletion
26.48
+2.72%
25.78
+16.41%
22.14
+12.93%
19.61
Depreciation
26.48
+2.72%
25.78
+16.41%
22.14
+12.93%
19.61
Depreciation And Amortization
26.48
+2.72%
25.78
+16.41%
22.14
+12.93%
19.61
Other Non Cash Items
7.06
-80.16%
35.60
+10463.50%
0.34
+27.65%
0.26
Stock Based Compensation
88.28
+16.20%
75.98
-1.59%
77.20
+33.71%
57.74
Provisionand Write Offof Assets
99.67
+35.67%
73.46
+5.51%
69.63
+19.33%
58.35
Asset Impairment Charge
4.46
+595.48%
0.64
-94.21%
11.08
-52.18%
23.16
Operating Gains Losses
—
7.59
—
—
Unrealized Gain Loss On Investment Securities
-5.71
-200.26%
-1.90
0.00
0.00
Change In Working Capital
-91.70
+7.49%
-99.12
+2.87%
-102.05
-55.77%
-65.51
Change In Receivables
-95.43
-3.82%
-91.92
-13.21%
-81.19
-31.30%
-61.84
Changes In Account Receivables
-95.43
-3.82%
-91.92
-13.21%
-81.19
-31.30%
-61.84
Change In Inventory
-8.51
-3700.00%
-0.22
-122.88%
0.98
+119.17%
-5.11
Change In Prepaid Assets
-5.38
-201.41%
5.30
+148.07%
-11.04
-1180.28%
-0.86
Change In Payables And Accrued Expense
28.04
+478.56%
-7.41
-142.76%
17.32
+50.91%
11.48
Change In Accrued Expense
—
—
19.30
+33.34%
14.47
Change In Payable
—
—
-1.97
+34.08%
-2.99
Change In Account Payable
—
—
-1.97
+34.08%
-2.99
Change In Other Working Capital
1.27
+439.30%
-0.37
-246.67%
0.26
+12650.00%
0.00
Change In Other Current Assets
-2.89
-189.85%
3.22
+114.14%
-22.79
-267.53%
-6.20
Change In Other Current Liabilities
-8.79
-13.96%
-7.72
-38.06%
-5.59
-87.30%
-2.98
Investing Cash Flow
-277.06
-125.28%
-122.98
-10072.29%
-1.21
+97.69%
-52.43
Cash Flow From Continuing Investing Activities
-277.06
-125.28%
-122.98
-10072.29%
-1.21
+97.69%
-52.43
Net PPE Purchase And Sale
-46.34
-36.53%
-33.94
+16.04%
-40.42
-35.51%
-29.83
Purchase Of PPE
-46.34
-36.53%
-33.94
+16.04%
-40.42
-35.51%
-29.83
Capital Expenditure
-46.34
+5.31%
-48.94
-21.07%
-40.42
-35.51%
-29.83
Net Investment Purchase And Sale
-230.71
-211.60%
-74.04
-288.81%
39.22
+273.49%
-22.60
Purchase Of Investment
-468.41
-167.30%
-175.24
-4.76%
-167.28
+11.29%
-188.57
Sale Of Investment
237.70
+134.88%
101.20
-50.99%
206.50
+24.42%
165.97
Net Intangibles Purchase And Sale
0.00
+100.00%
-15.00
0.00
0.00
Purchase Of Intangibles
0.00
+100.00%
-15.00
0.00
0.00
Financing Cash Flow
12.61
-97.53%
511.38
+5697.97%
8.82
-66.99%
26.72
Cash Flow From Continuing Financing Activities
12.61
-97.53%
511.38
+5697.97%
8.82
-66.99%
26.72
Net Issuance Payments Of Debt
0.00
-100.00%
619.84
0.00
-100.00%
13.53
Issuance Of Debt
0.00
-100.00%
736.25
0.00
-100.00%
35.00
Repayment Of Debt
0.00
+100.00%
-116.41
0.00
+100.00%
-21.47
Long Term Debt Issuance
0.00
-100.00%
736.25
0.00
-100.00%
35.00
Long Term Debt Payments
0.00
+100.00%
-116.41
0.00
+100.00%
-21.47
Net Long Term Debt Issuance
0.00
-100.00%
619.84
0.00
-100.00%
13.53
Net Common Stock Issuance
0.00
+100.00%
-25.00
0.00
0.00
Common Stock Payments
0.00
+100.00%
-25.00
0.00
0.00
Repurchase Of Capital Stock
0.00
+100.00%
-25.00
0.00
0.00
Proceeds From Stock Option Exercised
12.61
+48.79%
8.47
-3.93%
8.82
-33.09%
13.18
Net Other Financing Charges
—
-91.93
—
-0.08
Changes In Cash
-183.59
-146.86%
391.79
+1022.07%
-42.49
+12.81%
-48.73
Effect Of Exchange Rate Changes
0.00
+116.67%
-0.01
+96.45%
-0.17
0.00
Beginning Cash Position
427.95
+1083.08%
36.17
-54.11%
78.83
-38.20%
127.56
End Cash Position
244.37
-42.90%
427.95
+1083.08%
36.17
-54.11%
78.83
Free Cash Flow
34.52
+175.78%
-45.55
+49.68%
-90.53
-71.31%
-52.84
Interest Paid Supplemental Data
3.77
0.00
0.00
-100.00%
3.32
Income Tax Paid Supplemental Data
0.87
-13.70%
1.01
-48.86%
1.97
+586.06%
0.29
Amortization Of Securities
-3.13
-131.63%
-1.35
+73.21%
-5.04
-963.29%
-0.47
Common Stock Issuance
—
—
—
0.00
Issuance Of Capital Stock
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category